180
Views
0
CrossRef citations to date
0
Altmetric
CLINICAL TRIAL REPORT

Effect of High-Fat Meal on the Pharmacokinetics and Safety of Valsartan/Amlodipine Fixed Dose Combination Tablets in Healthy Subjects

, , , , , ORCID Icon & show all
Pages 43-51 | Received 16 Aug 2023, Accepted 29 Dec 2023, Published online: 11 Jan 2024

Figures & data

Figure 1 Subjects flow chart. Flow chart of the subjects in the fasted state (A). Flow chart of the subjects in the fed state (B). N: the number of subjects.

Figure 1 Subjects flow chart. Flow chart of the subjects in the fasted state (A). Flow chart of the subjects in the fed state (B). N: the number of subjects.

Table 1 The Ingredient List of High-Fat Meal

Table 2 Demographic Information and Baseline Information of Subjects in Groups

Figure 2 Arithmetic mean (SE) plasma concentration versus time profiles of valsartan (A), amlodipine (B) after single oral dose administration of valsartan/amlodipine tablet (80/5mg) under fed and fasted conditions.

Figure 2 Arithmetic mean (SE) plasma concentration versus time profiles of valsartan (A), amlodipine (B) after single oral dose administration of valsartan/amlodipine tablet (80/5mg) under fed and fasted conditions.

Table 3 Mean Pharmacokinetic Parameter Values for Valsartan and Amlodipine